Hypertension Journal

Register      Login

VOLUME 2 , ISSUE 3 ( July-September, 2016 ) > List of Articles


Hypertension and Pregnancy: Mechanisms and Management

Mie Saiki, Vesna D Garovic

Citation Information : Saiki M, Garovic VD. Hypertension and Pregnancy: Mechanisms and Management. Hypertens J 2016; 2 (3):131-138.

DOI: 10.5005/jp-journals-10043-0045

Published Online: 01-03-2016

Copyright Statement:  Copyright © 2016; The Author(s).


How to cite this article

Saiki M, Garovic VD. Hypertension and Pregnancy: Mechanisms and Management. Hypertens J 2016;2(3):131-138.

PDF Share
  1. Am J Obstet Gynecol 2000 Jul;183(1):S1-S22.
  2. Report of the american college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol 2013 Nov;122(5):1122-1131.
  3. HELLP! A cry for laboratory assistance: a comprehensive review of the HELLP syndrome highlighting the role of the laboratory. Hematopathol Mol Hematol 1998;11 (3-4):147-171.
  4. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001 Apr;97(4):533-538.
  5. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986 Oct;93(10):1049-1059.
  6. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 1994 Aug;101(8):669-674.
  7. Regulation of human placental development by oxygen tension. Science 1997 Sep;277(5332):1669-1672.
  8. Excess placental soluble fms-like tyrosine kinase 1 (sflt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003 Mar;111(5):649-658.
  9. Low placental growth factor across pregnancy identifies a subset of women with preterm preeclampsia: Type 1 versus type 2 preeclampsia? Hypertension 2012 Jul;60(1):239-246.
  10. Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. JAMA 1999 Jul;282(4):356-362.
  11. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin at1 receptor. J Clin Invest 1999 Apr;103(7):945-952.
  12. End-tidal carbon monoxide measurements in women with pregnancy-induced hypertension and preeclampsia. Am J Obstet Gynecol 2000 Oct;183(4):900-903.
  13. Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide 2000 Aug;4(4):441-458.
  14. Is cellular fibronectin a biological marker for pre-eclampsia? Eur J Obstet Gynecol Reprod Biol 2001 Jul;97(1):40-45.
  15. Biochemical corroboration of endothelial involvement in severe preeclampsia. Am J Obstet Gynecol 1995 Jan;172(1 Pt 1):202-203.
  16. Plasma p selectin (gmp-140) and glycocalicin are elevated in preeclampsia and eclampsia: their significances. Am J Obstet Gynecol 1996 Jan;174(1 Pt 1): 272-277.
  17. Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol 1997 Aug;177(2):443-449.
  18. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol 1994 Dec;84(6):937-940.
  19. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995 Jan;102(1):20-25.
  20. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstet Gynecol 1996 Nov;175(5):1365-1370.
  21. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv 2011 Aug;66(8):497-506.
  22. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012 Feb;125(7):911-919.
  23. Redefining preeclampsia using placenta-derived biomarkers. Hypertension 2013 May;61(5):932-942.
  24. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol 2002 Feb;155(3):203-209.
  25. Strategy for standardization of preeclampsia research study design. Hypertension 2014 Jun;63(6):1293-1301.
  26. Is in vitro fertilization associated with preeclampsia? A propensity score matched study. BMC Pregnancy Childbirth 2014 Feb;14(1):1-7.
  27. The effect of early diagnosis and treatment on maternal and fetal outcomes in patients with hellp syndrome. Biochem Medica 2007 Jun;17(1):60-70.
  28. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2010 Nov;CD000025.
  29. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007 Apr;(2):CD004659.
  30. H-S. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2007 Jan;(1):CD002252.
  31. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000 Jan;355(9198):87-92.
  32. Preeclampsia: new thoughts on an ancient problem. J Clin Hypertens (Greenwich) 2000 Mar;2(2):115-123.
  33. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med 2015 Jan;372(5):407-417.
  34. Fetal origins of coronary heart disease. BMJ 1995 Jul;311(6998):171-174.
  35. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007 Nov;335(7627):974.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.